tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Timur Ivannikov, 10 are a BUY (71.43%), 4 are a HOLD (28.57%).
Analyst Timur Ivannikov, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 62.5% that have a potential upside of 51.58% achieved within 453 days.
Timur Ivannikov’s has documented 20 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RCKT, Rocket Pharmaceuticals at 05-May-2023.
Analyst best performing recommendations are on CBIO (CATALYST BIOSCIENCES).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS) at 7/8/2022. The price target of $22 was fulfilled within 159 days with a profit of $5.34 (32.05%) receiving and performance score of 2.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$-14.86 (-83.20%)
$4
2 years 7 months 18 days ago
(31-Mar-2022)
5/5 (100%)
$1.92 (177.78%)
621
Hold
3 years 2 days ago
(16-Nov-2021)
1/1 (100%)
$10.5 (123.53%)
959
Buy
$24
$23.52 (4900.00%)
5 years 10 months 14 days ago
(04-Jan-2019)
0/1 (0%)
$18.19 (313.08%)
What Year was the first public recommendation made by Timur Ivannikov?
